Variant "PCSK9:c.426C>G(p.Tyr142*)"
Search result: 1 record
Variant information
Gene:
Variant:
PCSK9:c.426C>G(p.Tyr142*) 
Genomic location:
chr1:55512222(hg19) 
HGVS:
SO Term RefSeq
protein_coding NM_174936.3:c.426C>G(p.Tyr142*)
protein_coding 2P4E:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 2PMW:A_81-A_142:NM_174936.3:c.426C>G
protein_coding 2QTW:A_81-A_142:NM_174936.3:c.426C>G
protein_coding 2W2M:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 2W2N:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 2W2P:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 2W2Q:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 3BPS:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 3GCW:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 3GCX:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 3H42:A_81-A_142:NM_174936.3:c.426C>G
protein_coding 3SQO:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 4NE9:C_81-C_142:NM_174936.3:c.426C>G
protein_coding 4NE9:P_81-P_142:NM_174936.3:c.426C>G
protein_coding 4NMX:A_81-A_142:NM_174936.3:c.426C>G
protein_coding 4OV6:A_81-A_142:NM_174936.3:c.426C>G
protein_coding 4OV6:D_81-D_142:NM_174936.3:c.426C>G
pseudogene NR_110451.1:n.183-5729C>G
show all
dbSNP ID:
GWAS trait:
no data 
Modifier statisitcs
Record:
Disorder:
Reference:
Effect type:
Expressivity(1)  
Modifier effect:
Altered plasma levels of LDL cholesterol(1)  
Detail:
  • Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Altered plasma levels of LDL cholesterol 
    Evidence:
    These mutations were associated with a 28 percent reduction in mean ldl cholesterol and an 88 percent reduction in the risk of chd (p=0.008 for the reduction; hazard ratio, 0.11; 95 percent confidence interval, 0.02 to 0.81; p=0.03) 
    Effect:
    Reduce plasma levels of LDL cholesterol on the incidence of coronary events in a large population
    Reference:
    Title:
    Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
    Species studied:
    Human
    Abstract:
    A low plasma level of low-density lipoprotein (LDL) cholesterol is associated with reduced risk of coronary heart disease (CHD), but the effect of lifelong reductions in plasma LDL cholesterol is not known. We examined the effect of DNA-sequence variations that reduce plasma levels of LDL cholesterol on the incidence of coronary events in a large population.